Epstein–Barr Virus miRNA BART2-5p Promotes Metastasis of Nasopharyngeal Carcinoma by Suppressing RND3

This study shows that EBV-encoded BART2-5p miRNA suppresses expression of the RND3 Rho family GTPase, consequently promoting ROCK signaling, cell motility, and metastatic behavior of NPC cells. Nasopharyngeal carcinoma is an Epstein–Barr virus (EBV)-related malignancy. Recently, we found that the EBV-encoded miRNA BART2-5p was increased in the serum of patients with preclinical nasopharyngeal carcinoma and that the copy number positively correlated with disease progression. In this study, we established its role in nasopharyngeal carcinoma progression and explored underlying mechanisms and clinical significance. BART2-5p was an independent unfavorable prognostic factor for progression-free survival and its circulating abundance positively associated with distant metastasis. Ectopic expression of BART2-5p promoted migration and invasion of EBV-negative nasopharyngeal carcinoma cells, whereas genetic downregulation of BART2-5p in EBV-positive nasopharyngeal carcinoma cells decreased aggressiveness. Mechanistically, BART2-5p targeted RND3, a negative regulator of Rho signaling. Downregulation of RND3 phenocopied the effect of BART2-5p and reconstitution of RND3 rescued the phenotype. By suppressing RND3, BART2-5p activated Rho signaling to enhance cell motility. These findings suggest a novel role for EBV miRNA BART2-5p in promoting nasopharyngeal carcinoma metastasis and its potential value as a prognostic indicator or therapeutic target. Significance: This study shows that EBV-encoded BART2-5p miRNA suppresses expression of the RND3 Rho family GTPase, consequently promoting ROCK signaling, cell motility, and metastatic behavior of NPC cells.

[1]  D. Kwong,et al.  Evaluation of circulating EBV microRNA BART2‐5p in facilitating early detection and screening of nasopharyngeal carcinoma , 2018, International journal of cancer.

[2]  Sarah A. Boswell,et al.  RhoE Is a Pro-Survival p53 Target Gene that Inhibits ROCK I-Mediated Apoptosis in Response to Genotoxic Stress , 2016, Current Biology.

[3]  Anne W M Lee,et al.  Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  K. Yao,et al.  Epstein–Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma , 2015, Nature Communications.

[5]  Jianji Pan,et al.  Circulating Epstein–Barr virus microRNAs miR‐BART7 and miR‐BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment , 2015, International journal of cancer.

[6]  P. Murray,et al.  The Epstein–Barr virus and the pathogenesis of lymphoma , 2015, The Journal of pathology.

[7]  S. Tsao,et al.  The role of Epstein–Barr virus in epithelial malignancies , 2014, The Journal of pathology.

[8]  F. Marincola,et al.  EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN , 2014, Oncogene.

[9]  Zhen Lin,et al.  Comprehensive High-Throughput RNA Sequencing Analysis Reveals Contamination of Multiple Nasopharyngeal Carcinoma Cell Lines with HeLa Cell Genomes , 2014, Journal of Virology.

[10]  Yi Zheng,et al.  The Rho GTPase RhoE is a p53-regulated candidate tumor suppressor in cancer cells. , 2014, International journal of oncology.

[11]  F. Zindy,et al.  Silencing of the miR-17~92 cluster family inhibits medulloblastoma progression. , 2013, Cancer Research.

[12]  D. Fan,et al.  RhoE Promotes Metastasis in Gastric Cancer through a Mechanism Dependent on Enhanced Expression of CXCR4 , 2013, PloS one.

[13]  W. Fang,et al.  EBV-miR-BART1 is involved in regulating metabolism-associated genes in nasopharyngeal carcinoma. , 2013, Biochemical and biophysical research communications.

[14]  Mingyan Zhu,et al.  A Genome-Wide Screen of CREB Occupancy Identifies the RhoA Inhibitors Par6C and Rnd3 as Regulators of BDNF-Induced Synaptogenesis , 2013, PloS one.

[15]  P. Busson,et al.  Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs , 2012, Cancer.

[16]  D. Jin,et al.  The pathological roles of BART miRNAs in nasopharyngeal carcinoma , 2012, The Journal of pathology.

[17]  Kassem M. Makki,et al.  Rnd3/RhoE Is down‐regulated in hepatocellular carcinoma and controls cellular invasion , 2012, Hepatology.

[18]  Tianli Fan,et al.  RhoE functions as a tumor suppressor in esophageal squamous cell carcinoma and modulates the PTEN/PI3K/Akt signaling pathway , 2012, Tumor Biology.

[19]  D. Kwong,et al.  Profiling of Epstein‐Barr virus‐encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs , 2012, Cancer.

[20]  N. Raab-Traub,et al.  The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. , 2011, Virology.

[21]  A. Ridley,et al.  Rnd proteins: Multifunctional regulators of the cytoskeleton and cell cycle progression , 2010, BioEssays : news and reviews in molecular, cellular and developmental biology.

[22]  Kai-Ping Chang,et al.  Characterization of Epstein-Barr Virus miRNAome in Nasopharyngeal Carcinoma by Deep Sequencing , 2010, PloS one.

[23]  A. Hatzigeorgiou,et al.  Editing of Epstein-Barr Virus-encoded BART6 MicroRNAs Controls Their Dicer Targeting and Consequently Affects Viral Latency* , 2010, The Journal of Biological Chemistry.

[24]  S. Jonjić,et al.  Modulation of natural killer cell activity by viruses. , 2010, Current opinion in microbiology.

[25]  Muneesh Tewari,et al.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.

[26]  Raymond Wai-Ming Lung,et al.  Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. , 2009, Neoplasia.

[27]  Noam Stern-Ginossar,et al.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. , 2009, Cell host & microbe.

[28]  A. Aplin,et al.  Rnd3 regulation of the actin cytoskeleton promotes melanoma migration and invasive outgrowth in three dimensions. , 2009, Cancer research.

[29]  Katherine Cosmopoulos,et al.  Comprehensive Profiling of Epstein-Barr Virus MicroRNAs in Nasopharyngeal Carcinoma , 2008, Journal of Virology.

[30]  D. Kwong,et al.  An Epstein-Barr virus–encoded microRNA targets PUMA to promote host cell survival , 2008, The Journal of experimental medicine.

[31]  Feroz Sarkari,et al.  Epstein-Barr Nuclear Antigen 1 Contributes to Nasopharyngeal Carcinoma through Disruption of PML Nuclear Bodies , 2008, PLoS pathogens.

[32]  K. Roemer,et al.  Epstein–Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5 , 2007, Nucleic acids research.

[33]  A. Ruusala,et al.  Taking Rho GTPases to the next level: the cellular functions of atypical Rho GTPases. , 2007, Experimental cell research.

[34]  María Inés Torres,et al.  Exogenous nucleosides accelerate differentiation of rat intestinal epithelial cells , 2007, British Journal of Nutrition.

[35]  H. Adami,et al.  The Enigmatic Epidemiology of Nasopharyngeal Carcinoma , 2006, Cancer Epidemiology Biomarkers & Prevention.

[36]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[37]  Alexandra Schäfer,et al.  Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed , 2006, PLoS pathogens.

[38]  J. Kutok,et al.  Spectrum of Epstein-Barr virus-associated diseases. , 2006, Annual review of pathology.

[39]  A. Ridley,et al.  Function and regulation of RhoE. , 2005, Biochemical Society transactions.

[40]  A. Ridley,et al.  RhoE Inhibits Cell Cycle Progression and Ras-Induced Transformation , 2004, Molecular and Cellular Biology.

[41]  Anton J. Enright,et al.  Identification of Virus-Encoded MicroRNAs , 2004, Science.

[42]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[43]  S. Tsao,et al.  The significance of LMP1 expression in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.

[44]  P. Cohen,et al.  Phosphorylation of the regulatory subunit of smooth muscle protein phosphatase 1M at Thr850 induces its dissociation from myosin , 2002, FEBS letters.

[45]  P. Scambler,et al.  RhoE Regulates Actin Cytoskeleton Organization and Cell Migration , 1998, Molecular and Cellular Biology.

[46]  K. Kaibuchi,et al.  Formation of Actin Stress Fibers and Focal Adhesions Enhanced by Rho-Kinase , 1997, Science.

[47]  K. Yao,et al.  Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[48]  Z. Sizhong,et al.  Cytogenetic studies on an epithelial cell line derived from poorly differentiated nasopharyngeal carcinoma , 1983, International journal of cancer.

[49]  Y. F. Poon,et al.  Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx , 1980, International journal of cancer.

[50]  Pelayo Vilar,et al.  Nasopharyngeal Carcinoma , 1966 .

[51]  M. Epstein,et al.  VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. , 1964, Lancet.

[52]  A. Ridley,et al.  RhoE Is required for keratinocyte differentiation and stratification. , 2009, Molecular biology of the cell.

[53]  M. Yu,et al.  Nasopharyngeal carcinoma: epidemiology and dietary factors. , 1991, IARC scientific publications.